Orchid Pharma gets EIR report from USFDA for Chennai facility

08 Jan 2018 Evaluate

Orchid Pharma has received the Establishment Inspection Report (EIR) from US Food and Drug Administration (USFDA) based on the successful inspection closure for the Post-marketing Adverse Drug Experience reporting inspection (PADE) conducted at Orchid Towers 313, Valluvar Kottam High Road, Nungambakkam, Chennai, Tamil Nadu, India. The facility was inspected by USFDA in the month of June 2017.

Orchid Pharma is a pharmaceutical company engaged in development and manufacture of active pharmaceutical ingredients and finished dosage forms. It is also engaged in research of new drugs.

Orchid Pharma Share Price

865.95 0.80 (0.09%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×